UNASSIGNED: An American Hepato-Pancreato-Biliary Association (AHPBA)-sponsored consensus meeting of expert panellists was convened on 15 January 2014 to review current evidence on the management of @entity1086 in order to establish practice guidelines. In summary, within high incidence areas, the assessment of routine gallbladder specimens should include the microscopic evaluation of a minimum of three sections and the cystic duct margin; specimens with @entity1141 or proven @entity5 should be extensively sampled. Provided the @entity1 is medically fit for surgery, data support the resection of all @entity1127 of >1.0  cm in diameter and those with imaging evidence of @entity455 . The minimum staging evaluation of @entity1 with suspected or proven @entity1086 includes contrasted cross-sectional imaging and diagnostic laparoscopy. Adequate lymphadenectomy includes assessment of any suspicious regional nodes, evaluation of the aortocaval nodal basin, and a goal recovery of at least six nodes. @entity1 with confirmed metastases to N2 nodal stations do not benefit from radical resection and should receive systemic and/or palliative treatments. Primary resection of @entity1 with early T-stage (T1b-2) disease should include en bloc resection of adjacent @entity409 . @entity1 with T1b, T2 or T3 disease that is incidentally identified in a cholecystectomy specimen should undergo re-resection unless this is contraindicated by advanced disease or poor performance status. Re-resection should include complete portal lymphadenectomy and bile duct resection only when needed to achieve a negative margin (R0) resection. @entity1 with preoperatively staged T3 or T4 N1 disease should be considered for clinical trials of neoadjuvant chemotherapy. Following R0 resection of T2-4 disease in N1 @entity1086 , @entity1 should be considered for adjuvant systemic chemotherapy and/or chemoradiotherapy.

XXXX : expert consensus statement.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity455 :: ('MESH:D014652', 'Disease') :: ['vascular stalks'] @entity1127 :: ('MESH:D011127', 'Disease') :: ['gallbladder polyps'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer'] @entity409 :: ('MESH:D008107', 'Disease') :: ['liver parenchyma'] @entity1086 :: ('MESH:D005706', 'Disease') :: ['gallbladder cancer', 'gallbladder carcinoma'] @entity1141 :: ('MESH:C535662', 'Disease') :: ['dysplasia']
@entity1086 :: (MESH:D005706,Disease) :: ['Gallbladder Cancer']
